ASGCT 2023—Gene therapy is becoming medicine

dc.contributor.authorHerzog, Roland W.
dc.contributor.authorBricker-Anthony, Courtney
dc.contributor.departmentPediatrics, School of Medicine
dc.date.accessioned2024-09-19T13:14:29Z
dc.date.available2024-09-19T13:14:29Z
dc.date.issued2023
dc.eprint.versionFinal published version
dc.identifier.citationHerzog RW, Bricker-Anthony C. ASGCT 2023-Gene therapy is becoming medicine. Mol Ther. 2023;31(7):1859. doi:10.1016/j.ymthe.2023.06.003
dc.identifier.urihttps://hdl.handle.net/1805/43438
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.ymthe.2023.06.003
dc.relation.journalMolecular Therapy
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectAmerican Society of Gene Therapy
dc.subjectPrecision
dc.subjectGene therapy
dc.subjectGene editing
dc.titleASGCT 2023—Gene therapy is becoming medicine
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362409/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Herzog2023Gene-PP.pdf
Size:
160.6 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: